BRCA1 Patent
Links shared publicly online about this topic
Judge Rules Myriad Cannot Patent BRCA1 and BRCA2 Genes
hcplive.com — “A US district court invalidated 7 of 23 of Myriad” View full resource at hcplive.com
Most Recently Shared on April 22, 2010 at 7:54 pm By:
Story on gene patents posted to ONClive.com at http://www.hcplive.com/oncology/articles/BRCA_Patent.
Supreme Court Asks for Reconsideration on BRCA1 and BRCA2 Patents
onclive.com — “The US Supreme Court has asked an appellate court to reconsider its decision regarding patents held on two genes.” View full resource at onclive.com
Most Recently Shared on March 27, 2012 at 8:40 pm By:
Supreme Court Asks for Reconsideration on BRCA1 and BRCA2 Patents http://t.co/KhhtpOYX
BRCA1: A Race Still Not Finished « EGMN: Notes from the Road
egmnblog.wordpress.com — “BRCA1: A Race Still Not Finished « EGMN: Notes from the Road” View full resource at egmnblog.wordpress.com
Most Recently Shared on March 31, 2010 at 6:51 pm By:
Bob Finn - Medical News Net Health News
Reading blog post by @mitchelzoler placing BRCA1 gene in context of recent gene patent issues http://bit.ly/c7MKDc
Breast and ovarian cancer: Myriad Genetics BRCA1 and BRCA2 gene patents get court approval - latimes.com
latimes.com — “A court of appeals has affirmed patents on the BRCA1 and BRCA2 genes held by Myriad Genetics, which sells tests to determine if people carry the gene variants. BRCA1 and BRCA2 increase a woman's likelihood of developing breast or ovarian cancer.” View full resource at latimes.com
Most Recently Shared on July 29, 2011 at 10:44 pm By:
LA Times Health News Health News
Breast cancer: Gene patents get court approval http://lat.ms/qqZoHJ
Legal battle over BRCA1 and BRCA2 patents continues - 2011 - American Journal of Medical Genetics Part A - Wiley Online Library
onlinelibrary.wiley.com — “Legal battle over BRCA1 and BRCA2 patents continues - 2011 - American Journal of Medical Genetics Part A - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on October 23, 2011 at 11:16 pm By:
Legal battle over BRCA1 and BRCA2 patents continues: (Source: American Journal of Medical Genetics Part A) http://t.co/zl9E761t
Gene Patents Big Business - Topix
topix.com — “Gene Patents Big Business - Topix” View full resource at topix.com
Most Recently Shared on May 24, 2011 at 3:40 am By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
Gene Patents Big Business: BACKGROUND: According to the National Cancer Institute, the BRCA1 and BRCA2 are human... http://bit.ly/jHgPTu
Genes improperly granted patents
news-medical.net — “Some time mid last year six breast cancer patients sued reputed Myriad Genetics, a company that holds patent of two vital genes BRCA1 and BRCA2 that play a role in increasing the risk of breast and ovarian cancers. The fees that the company charges for these genetic tests is a whopping $3,000 which these women claim they cannot afford and the most important of all these women cannot get a second opinion regarding the tests since no one else does them.” View full resource at news-medical.net
Most Recently Shared on April 2, 2010 at 12:24 am By:
Genetics News: Genes improperly granted patents: Some time mid last year six breast cancer patients sued reputed... http://buzzup.com/sef7
Patenting Nature And Seattle Biotech
kuow.org — “KUOW Puget Sound Public Radio: NPR News and Information” View full resource at kuow.org
Most Recently Shared on April 29, 2010 at 8:04 pm By:
Matt Mealiffe, M.D. Geneticist, Doctor, Internist, and Physician
RT @libbyshope: KUOW podcast: Recent court decision re patentability of BRCA1/BRCA2 genes http://dld.bz/bGvf
Legality of Human Gene Patents Questioned in Federal Court - WSJ.com
online.wsj.com — “A U.S. federal appeals panel, hearing a case over Myriad Genetics patents for identifying breast- and ovarian-cancer risk, probed whether it makes sense to continue allowing the patenting of human gene sequencing.” View full resource at online.wsj.com
Most Recently Shared on April 4, 2011 at 10:07 pm By:
Hisham Rana, MD Doctor and Physician
News: Legality of human gene patents questioned in U.S. federal court http://on.wsj.com/enuCWJ - Myriad Genetics BRCA1 and BRCA2. #health
Taking Stock After Gene Patents Are Invalidated - NYTimes.com
nytimes.com — “Many biotechnology stocks fell as investors struggled to understand the impact of a ruling that threw out parts of two gene patents and called into question thousands more.” View full resource at nytimes.com
Most Recently Shared on March 31, 2010 at 4:52 am By:
Hisham Rana, MD Doctor and Physician
This article provides another angle to the BRCA1 / BRCA2 gene patent topic that has dominated my tweeting today. http://nyti.ms/bOUqgh
Judge Rules BRCA Genes Can Be Patented, Overturning Previous Decision
onclive.com — “On July, 29, 2011, a US appeals court sided with Myriad Genetics, Inc’s patents on the BRCA1 and BRCA2 genes.” View full resource at onclive.com
Most Recently Shared on August 1, 2011 at 9:24 pm By:
Judge Rules BRCA Genes Can Be Patented, Overturning Previous Decision http://t.co/Xz19QCd
Myriad breast cancer patent very broad, study finds | Reuters
feeds.reuters.com — “WASHINGTON (Reuters) - Myriad Genetics' disputed patent on the BRCA1 breast cancer gene is surprisingly broad and could interfere with future research, three experts said on Tuesday. Their ongoing research” View full resource at feeds.reuters.com
Most Recently Shared on March 16, 2010 at 11:36 pm By:
Myriad breast cancer patent very broad, study finds http://link.reuters.com/fag24j
Federal Appeals Court Partially Reverses Lower Court's Ruling On Case That Challenges Patents On Two Human Genes
medicalnewstoday.com — “In a 2-1 decision, a federal appeals court has partially reversed a lower court's ruling in a case challenging patents on two human genes, BRCA1 and BRCA2, associated with hereditary breast and ov” View full resource at medicalnewstoday.com
Most Recently Shared on August 2, 2011 at 8:06 am By:
Federal Appeals Court Partially Reverses Lower Court's Ruling On Case That Challenges Patents On Two Human Gene... http://bit.ly/n4DVcl
Defending the Body Corporate: Appeals Court Puts Gene Patents on the Stand: Scientific American
scientificamerican.com — “After an unanticipated setback a year ago, Myriad Genetics has taken its case to a federal appeals court to retain its patents for the BRCA1 and BRCA2 genes” View full resource at scientificamerican.com
Most Recently Shared on April 7, 2011 at 8:10 pm By:
Scientific American Health Magazine
Defending the Body Corporate: Appeals Court Puts Gene Patents on the Stand http://bit.ly/f0TOHQ
Legal bid against breast cancer gene patents - ABC News (Australian Broadcasting Corporation)
abc.net.au — “Women in the United States are being charged $3,700 for a breast cancer genetic test because only one company has the patent over the two key breast cancer genes, BRCA 1 and BRCA 2.” View full resource at abc.net.au
Most Recently Shared on September 29, 2009 at 2:31 pm By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
Legal bid against breast cancer gene patents - ABC Online http://bit.ly/fnQ9b
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Editor
Editors of Oncology & Biotech News/Oncology Net Guide/OncNurse/Contemporary Oncology, on cancer news from pharma, trials, technology, & more.
-
Editor
Editors of Oncology & Biotech News/Oncology Net Guide/OncNurse/Contemporary Oncology, on cancer news from pharma, trials, technology, & more.
-
Bob Finn - Medical News Net
Bringing you the latest news from scientific meetings and the policy world. Check us out at www.internalmedicinenews.com
Advertisement
